KCI/KMQ致力于临床前一体化CRO服务，促进生物医药的发展

About
contact us

    KCI BioTech (Suzhou) Inc.
    Tel：0512-69998806
    Ministry of Commerce：0512-69998806-8012
    BD：
    East and South China：Ms. Gu 15378638068
    North China, East China：Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department：0512-69998806-8022
    Tumor business：0512-69998806-8058
    Non tumor business：0512-69998806-8026
    Pathogenic microorganism business：0512-69998806-8037
    Integrated Service Platform：0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

       KCI BioTech (Suzhou) Inc. and its wholly-owned subsidiary Jiangsu KMQ BioTech Inc. are committed to providing comprehensive preclinical new drug discovery and development services for global pharmaceutical companies and research institutions, and establishing a professional and efficient drug research and development evaluation system.

       The company has two internationally advanced laboratory animal facilities in Suzhou and Nantong, both of which have obtained international AAALAC certification, with a total area of over 18000 square meters; We have established a full range of laboratory animal platforms including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets, and non-human primates, over 400 kind of animal for modelsoncological and non-oncological diseases, ABSL-2/BSL-2 microbiology experimental platforms, pathology, cell and molecular biology, pharmacokinetics, medical imaging, and other research service platforms. With a professional integrated R&D team and rich experience in in vivo pharmacology and pharmacodynamics, we have gained a large market share in the high technical barriers and huge demand of preclinical research fields. We have cooperated with over 500 well-known pharmaceutical R&D companies both domestically and internationally, and have completed over 100 domestic and international new drug application projects.